Back
Also listed as
HLNCF
OTC
Day Range
$9.65
$9.77
52-Week Range
$8.71
$11.42
Volume
14,484,580
50D / 200D Avg
$10.51
/
$9.91
Prev Close
$9.93
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 26.5 | 0.3 |
| P/B | 2.6 | 2.9 |
| ROE % | 10.0 | 3.7 |
| Net Margin % | 15.1 | 3.8 |
| Rev Growth 5Y % | 3.1 | 10.0 |
| D/E | 0.5 | 0.2 |
Analyst Price Target
Hold
$10.20
+5.2%
Forward P/E
24.1
Forward EPS
$0.41
EPS Growth (est.)
+0.0%
Est. Revenue
11 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.56
$0.55 – $0.57
|
13 B | 2 |
| FY2029 |
$0.55
$0.54 – $0.56
|
13 B | 4 |
| FY2028 |
$0.50
$0.45 – $0.54
|
12 B | 6 |
Key Takeaways
Revenue grew 3.11% annually over 5 years — modest growth
ROE of 10.01% — decent returns on equity
Net margin of 15.11% shows strong profitability
Generating 1.97B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 7.07%
Cash machine — converts 120.88% of earnings into free cash flow
Growth
Revenue Growth (5Y)
3.11%
Revenue (1Y)-3.96%
Earnings (1Y)13.07%
FCF Growth (3Y)5.70%
Quality
Return on Equity
10.01%
ROIC7.27%
Net Margin15.11%
Op. Margin22.44%
Safety
Debt / Equity
0.52
Current Ratio0.92
Interest Coverage7.28
Valuation
P/E Ratio
26.49
P/B Ratio2.63
EV/EBITDA20.85
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3.96% | Revenue Growth (3Y) | -2.30% |
| Earnings Growth (1Y) | 13.07% | Earnings Growth (3Y) | 24.67% |
| Revenue Growth (5Y) | 3.11% | Earnings Growth (5Y) | 4.07% |
| Profitability | |||
| Revenue (TTM) | 10.79B | Net Income (TTM) | 1.63B |
| ROE | 10.01% | ROA | 5.01% |
| Gross Margin | 64.77% | Operating Margin | 22.44% |
| Net Margin | 15.11% | Free Cash Flow (TTM) | 1.97B |
| ROIC | 7.27% | FCF Growth (3Y) | 5.70% |
| Safety | |||
| Debt / Equity | 0.52 | Current Ratio | 0.92 |
| Interest Coverage | 7.28 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 26.49 | P/B Ratio | 2.63 |
| P/S Ratio | 4.00 | PEG Ratio | 1.65 |
| EV/EBITDA | 20.85 | Dividend Yield | 0.02% |
| Market Cap | 43.19B | Enterprise Value | 50.46B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10.79B | 11.23B | 11.30B | 10.86B | 9.55B |
| Net Income | 1.63B | 1.44B | 1.05B | 1.06B | 1.39B |
| EPS (Diluted) | 0.36 | 0.32 | 0.24 | 0.24 | 0.30 |
| Gross Profit | 6.99B | 6.95B | 6.96B | 6.58B | 5.95B |
| Operating Income | 2.42B | 2.21B | 2.00B | 1.83B | 1.64B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 32.57B | 34.32B | 34.06B | 34.82B | 34.45B |
| Total Liabilities | 16.12B | 18.09B | 17.33B | 18.36B | 7.97B |
| Shareholders' Equity | 16.40B | 16.17B | 16.61B | 16.33B | 26.36B |
| Total Debt | 8.59B | 10.10B | 9.46B | 10.44B | 991.00M |
| Cash & Equivalents | 1.32B | 2.20B | 1.04B | 684.00M | 414.00M |
| Current Assets | 4.54B | 5.72B | 4.82B | 4.06B | 5.25B |
| Current Liabilities | 4.92B | 5.81B | 4.64B | 4.37B | 4.24B |